KRFK (TFA)

CAT: 0804-HY-P3970A-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-P3970A-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
KRFK TFA, a peptide derived from TSP-1, can activate TGF-β. KRFK TFA promotes TGF-β-mediated signaling and its downstream role, independent of thrombospondin (TSP) receptors such as CD47 and CD36. KRFK TFA can be used for chronic ocular surface inflammatory disorders reseach[1].
UNSPSC
12352209
Target
TGF-β Receptor
Type
Peptides
Related Pathways
TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/krfk-tfa.html
Purity
99.90
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CCCCN)C(O)=O)=O)=O)[C@H](CCCCN)N.OC(C(F)(F)F)=O.[x]
Molecular Formula
C27H47N9O5.xC2HF3O2
Molecular Weight
577.73 (free base)
References & Citations
[1]Soriano-Romaní L, et al. Topical Application of TGF-β-Activating Peptide, KRFK, Prevents Inflammatory Manifestations in the TSP-1-Deficient Mouse Model of Chronic Ocular Inflammation. Int J Mol Sci. 2018 Dec 20;20 (1) :9.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P3970KRFK
HY-P5744ASPPHPSPAFSPAFDNLYYWDQ (TFA)
HY-P10068ALAH5 (TFA)
HY-P0322AGRGDSPK (TFA)
HY-111348ALamifiban (TFA)
HY-P5170CLIVILSPFVKT (TFA)
HY-109080ABelvarafenib (TFA)
HY-P2203ASAHM1 (TFA)
HY-P3665ARIVTSEEVIIRDS (TFA)
HY-P5304ARTQLLWTPAAPTAMA (TFA)

Alternative Products

CatalogName
T76497-01KRFK
MBS3611039-01Dermorphin TFA
M40534-01Katacalcin TFA
M40541-01Tirzepatide TFA
M40587-01Chlorotoxin TFA
M40605-01Xenopsin TFA
M40612-01Tyroserleutide TFA
M40627-01CGGRGD TFA
M40631-01CysHHC10 TFA
M30175-01WKYMVM TFA

Popular Products